Citations 1
Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology
Loren, Alison W. , Bolaños‐Meade, Javier , Brammer, Jonathan E. , Cowden, Meredith , Stasi, Antonio Di , El‐Jawahri, Areej , Elmariah, Hany , Gundabolu, Krishna , Gutman, Jonathan A. , Ho, Vincent T. , Hoeg, Rasmus T. , Horwitz, Mitchell E. , Jamy, Omer , Dabaja, Mohamed Kharfan, Lee, Lauren , Luszcak, Christina, Magenau, John, Martin, Thomas , Mittal, Varun , Moreira, Jonathan , Muffly, Lori , Nakamura, Ryotaro , Nawas, Mariam, Ninos, Cameron , Oliai, Caspian , Pidala, Joseph A. , Randolph, Brion, Tessier, Jeffrey, Topal, Jeffrey , Varshavsky‐Yanovsky, Asya, Jones, Frankie, Stehman, Katie, Elmariah, Hany , Jamy, Omer , Muffly, Lori , Mielcarek, Marco B. , Kassim, Adetola A , Logan, Aaron C , Nawas, Mariam T. , Nieto, Yago , Oliai, Caspian H , Papanicolaou, Genovefa A. , Schroeder, Mark A. , Tzachanis, Dimitrios
Journal of the National Comprehensive Cancer Network | October 9, 2025 | Volume: 23 | Issue: 10 | Pages: No page available
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hematopoietic Cell Transplantation (HCT) provide expert, multidisciplinary recommendations for autologous and allogeneic HCT based on current evidence. The NCCN Guidelines focus on pretransplant recipient evaluation, hematopoietic cell mobilization, conditioning, and the diagnosis and management of graft-versus-host disease (GVHD), a common complication of allogeneic HCT that is associated with significant morbidity. This selection from the NCCN Guidelines for HCT focuses on the diagnosis, workup, and management of acute and chronic GVHD, as well as important supportive care considerations.